Raffles Medical Group (BSL.SI) Earnings Analysis
Raffles Medical Group (BSL.SI) next reports earnings on 2026-07-26. Trailing P/E 25.00.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does BSL.SI next report earnings?
| Next earnings date | 2026-07-26 |
|---|---|
| Consensus EPS estimate | n/a |
| Revenue estimate | 0.19B |
BSL.SI earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-02-22 | 0.0208 SGD | n/a | n/a | n/a |
| 2025-07-27 | 0.00865 SGD | n/a | n/a | n/a |
| 2025-02-24 | 0.017 SGD | n/a | n/a | n/a |
| 2024-07-29 | 0.00812 SGD | n/a | n/a | n/a |
BSL.SI valuation and analyst view
| Trailing P/E | 25.00 |
|---|---|
| Trailing EPS | 0.03817 SGD |
| Price / book | 1.67 |
| Dividend yield | 3.14% |
| Market cap | 1.74B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is Raffles Medical Group (BSL.SI)'s next earnings date?
Raffles Medical Group is next scheduled to report on 2026-07-26 and revenue estimate of 0.19B.
Did BSL.SI beat earnings last quarter?
Consensus estimate data was not available for BSL.SI's 2026-02-22 report.
What is BSL.SI's current P/E ratio and EPS?
BSL.SI trades at a trailing P/E of 25.00 on trailing EPS of 0.03817113616408944 SGD.
What do analysts rate BSL.SI?
BSL.SI has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.